Ripretinib

Item number	Size	Manual	Delivery time	Price
TGM-T8482-1mg	1 mg	-	7 - 10 business days*	67.00€
TGM-T8482-2mg	2 mg	-	7 - 10 business days*	96.00€
TGM-T8482-5mg	5 mg	-	7 - 10 business days*	164.00€
TGM-T8482-1mL	1 ml	-	7 - 10 business days*	208.00€
TGM-T8482-10mg	10 mg	-	7 - 10 business days*	282.00€
TGM-T8482-25mg	25 mg	-	7 - 10 business days*	482.00€
TGM-T8482-50mg	50 mg	-	7 - 10 business days*	702.00€
TGM-T8482-100mg	100 mg	-	7 - 10 business days*	967.00€
TGM-T8482-500mg	500 mg	-	7 - 10 business days*	1,943.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Ripretinib (DCC-2618) is an orally bioavailable inhibitor of (KIT) and (PDGFRA).... more

Close menu

Product information "Ripretinib"

Description: Ripretinib (DCC-2618) is an orally bioavailable inhibitor of (KIT) and (PDGFRA). Target: PDGFR, FLT, Apoptosis, VEGFR, c-Kit. Smiles: CCn1c2cc(NC)ncc2cc(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)c1=O. References: Schneeweiss M, et al. The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis. Haematologica. 2018 May,103(5):799-809.

Keywords:	DCC-2618
Supplier:	TargetMol
Supplier-Nr:	T8482

Properties

Application:	Targets proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1] (KIT, SCFR, CD117)
MW:	510.36 D
Formula:	C24H21BrFN5O2

Database Information

CAS :	1442472-39-0\| Matching products
KEGG ID :	K04363 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Ripretinib"

Write a review